CA
OSIR

Cliff Asness’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Cliff Asness’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,636
Closed -$152K – 2390
2015
Q4 		$152K Buy
14,636
+462
+3% +$6.27K ﹤0.01% 2186
2015
Q3 		$262K Buy
14,174
+3,008
+27% +$58.1K ﹤0.01% 1972
2015
Q2 		$217K Buy
+11,166
New +$198K ﹤0.01% 2089
2015
Q1 		– Sell
-11,972
Closed -$191K – 2577
2014
Q4 		$191K Sell
11,972
-10,400
-46% -$139K ﹤0.01% 2372
2014
Q3 		$282K Hold
22,372
– – ﹤0.01% 2216
2014
Q2 		$349K Hold
22,372
– – ﹤0.01% 2144
2014
Q1 		$294K Hold
22,372
– – ﹤0.01% 2273
2013
Q4 		$360K Buy
+22,372
New +$357K ﹤0.01% 2225

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Cliff Asness's OSIR Position: Q1 2016 in Review

Cliff Asness sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 14,636 shares — an estimated $152K sold.

Cliff Asness first reported a position in OSIR in Q4 2013 and held it in 8 quarters. The position peaked at $360K in Q4 2013. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

  • Cliff Asness reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Cliff Asness sold 14,636 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $152K.
  • Cliff Asness first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
  • Cliff Asness's Osiris Therapeutics, Inc. Common Stock position peaked at $360K in Q4 2013.
  • 80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.